Using multicenter ELISA validations, we selected three biomarkers (SEMA7A, SERPINA3, and ITIH4) and confirmed their efficacy in distinguishing NS from syphilis and other brain diseases, including infectious diseases. This evidence concerns the gene SEMA7A and syphilis.